Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial — Keitaro Senoo (2016) | RDL Network
Predictive abilities of the HAS-BLED and ORBIT bleeding risk scores in non-warfarin anticoagulated atrial fibrillation patients: An ancillary analysis from the AMADEUS trial
María Asunción Esteve‐Pastor, Amaya García-Fernández, Manuel Macı́as, Francisco Sogorb, Mariano Valdés, Vanessa Roldán, Javier Muñiz, Lina Badimón, Inmaculada Roldán, Vicente Bertoméu, Ángel Cequier, Professor Gregory Lip, Manuel Anguita, Francisco Marı́n
Discussion(0)
No comments yet. Be the first to comment.